Zobrazeno 1 - 10
of 599
pro vyhledávání: '"L. A. Valentino"'
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 24(4)
The development of high-titre inhibitory antibodies (inhibitors) against factor VIII (FVIII) remains a challenge in the management of patients with haemophilia A (HA). Patients with high-titre inhibitors are more likely to experience uncontrolled ble
Autor:
Lisa Patrone, A. Chybicka, D. V. Quon, V. Mamonov, Phillip Schroth, Andrzej Hellmann, W.-Y. Wong, L. A. Valentino
Publikováno v:
Journal of Thrombosis and Haemostasis
Background: Prophylaxis with factor (F)VIII is considered the optimal treatment for managing hemophilia A patients without inhibitors. Objectives: To compare the efficacy of two prophylaxis regimens (primary outcome) and of on-demand and prophylaxis
Autor:
L. A. Valentino
Publikováno v:
Journal of Thrombosis and Haemostasis. 8:1895-1902
Summary. Arthropathy is a frequent and serious complication of repeated joint bleeding in patients with hemophilia, resulting in pain, deformity, and disability. Although the pathogenesis of hemophilic arthropathy has not been fully elucidated, it ap
Autor:
Liang, Zhimin1 (AUTHOR), Ding, Zichuan2 (AUTHOR), Wang, Duan2 (AUTHOR), Guo, Yuchen1 (AUTHOR), Zhu, Ling1 (AUTHOR), Luo, Zeyu2 (AUTHOR) luozy@wchscu.cn, Li, Lingli1 (AUTHOR) lilingli2020@126.com
Publikováno v:
Orthopaedic Surgery. Dec2024, Vol. 16 Issue 12, p2897-2915. 19p.
Publikováno v:
Haemophilia. 10:134-146
Central venous access devices (CVADs) can facilitate repeated and/or urgent administration of coagulation factors in haemophilic patients. We conducted a systematic review and meta-analysis of complication rates and risk factors for poor outcome. For
Autor:
Albisetti M; University Children's Hospital, Zurich, Switzerland., Ardila J; Clínica Imbanaco Quirón Salud Hemophilia Center, IPS Especializada Coagulopathies Program, Universidad del Valle School of Public Health, Cali, Colombia., Astermark J; Department of Translational Medicine, Lund University, Lund, Sweden.; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Malmö, Sweden., Blatny J; Department of Paediatric Haematology and Biochemistry, University Hospital Brno and Masaryk University, Brno, Czech Republic and Hospital Bory, Bratislava, Slovakia., Carcao M; Division of Haematology/Oncology, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Chowdary P; Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free London NHS Foundation Trust, London, UK., Connell NT; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Crato M; European Haemopilia Consortium, Brussels, Belgium., Dargaud Y; French Reference Center for Hemophilia, Clinical Haemostasis Unit, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.; Universite Claude Bernard Lyon 1 (UCLB), Lyon, France., d'Oiron R; Centre de Référence de l'Hémophilie et des Maladies Hémorragiques Rares, Hôpital Bicêtre APHP, and HITh, UMR_S1176, INSERM, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France., Dunn AL; Nationwide Children's Hospital Division of Hematology, Oncology and Bone Marrow Transplant, Columbus, Ohio, USA., Escobar MA; University of Texas Health Science Center at Houston, Houston, Texas, USA., Ettingshausen CE; HZRM-Haemophilie Zentrum Rhein-Main, Frankfurt, Germany., Fischer K; Center for Benign Haematology, Thrombosis and Haemostasis Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands., Gouider E; Service d'hématologie biologique Hemophilia Center Aziza Othmana, University Tunis El Manar, Tunis, Tunisia., Harroche A; Service d'Hématologie Clinique Centre de Traitement de l'Hémophilie, Hôpital Necker Enfants Malades, AP-HP, Paris, France., Hermans C; Division of Adult Haematology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium., Jimenez-Yuste V; Hematology Department, Hospital Universitario La Paz-IdiPaz, Autonoma University, Madrid, Spain., Kaczmarek R; Indiana University School of Medicine, Indianapolis, Indiana, USA., Kenet G; The Israeli National Hemophilia Center and Thrombosis Research Institute, Sheba Medical Center, Tel Hashomer & Tel Aviv University, Ramat Gan, Israel., Khoo L; Haematology Department, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Klamroth R; Department for Internal Medicine and Vascular Medicine, Haemophilia Treatment Center, Vivantes Hospital im Friedrichshain, Berlin, Germany., Langer F; Department of Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany., Lillicrap D; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada., Mahlangu J; Department of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, Gauteng, South Africa., Male C; Department of Paediatrics, Medical University of Vienna, Vienna, Austria., Mancuso ME; Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Matsushita T; Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan., Meunier S; Hospices Civils de Lyon- French Reference Center for Hemophilia, Clinical Haemostasis Unit Lyon, Louis Pradel Hospital, Bron, France., Miesbach W; Medical Clinic 2, University Hospital Frankfurt, Frankfurt, Germany., Nolan B; Children's Health Ireland at Crumlin, Dublin, Ireland., Oldenburg J; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, Germany., O'Mahony B; Irish Haemophilia Society, Dublin, Ireland., Ozelo M; Department of Internal Medicine, School of Medical Sciences, Hemocentro UNICAMP, University of Campinas, Campinas, SP, Brazil., Pierce GF; World Federation of Hemophilia, Montreal, Quebec, Canada., Ramos G; Reference Laboratory in Haemostasis and Hematology, National University, Bogotà, Colombia., Recht M; Yale University, New Haven, Connecticut, USA.; National Bleeding Disorders Foundation, New York, New York, USA., Romero-Lux O; European Haemopilia Consortium, Brussels, Belgium., Rotellini D; National Bleeding Disorders Foundation, New York, New York, USA., Santoro RC; Centre for Hemorrhagic and Thrombotic Disorders, Azienda Ospedaliera-Universitaria Renato Dulbecco, Catanzaro, Italy., Singleton TC; OchsnerClinic Foundation, Pediatric Hematology and Bone Marrow Transplant, New Orleans, Louisiana, USA., Skinner MW; Institute for Policy Development Ltd, Washington, District of Columbia, USA.; McMaster University, Hamilton, Ontario, Canada., Srivastava A; Haematology Research Unit, St. Johns Research Institute and Department of Clinical Haematology, St. John's Medical College Hospital, Bengaluru, India., Susen S; Hemostasis and Transfusion Department, University of Lille, Lille University Hospital, Lille, France., Talks K; Newcastle Haemophilia Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Tran H; The Alfred Hospital, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., Valentino LA; Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, Illinois, USA., Windyga J; Department of Haemostasis Disorders and Internal Medicine, Laboratory of Haemostasis and Metabolic Diseases, Institute of Haematology and Transfusion Medicine, Warsaw, Poland., Yang R; Thrombosis and Hemostasis Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2024 Dec 06. Date of Electronic Publication: 2024 Dec 06.
Autor:
Valentino LA; Rush University Medical Center, Hemophilia and Thrombophilia Center, Chicago, Illinois, USA., Khair K; Haemnet, London, UK.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2024 Dec 04. Date of Electronic Publication: 2024 Dec 04.
Autor:
G. St Jean, Noah D. Cohen, K Kersting, J Huhn, L W Valentino, Suzanne Adams, David E. Anderson, A Desroches, Mandi J. Lopez, P O Mueller
Publikováno v:
Journal of the American Veterinary Medical Association. 217:376-383
Objective—To determine risk factors for development of sequestra in cattle and identify factors associated with a successful outcome. Design—Retrospective study. Animals—110 cattle. Procedure—Medical records of cattle treated at veterinary te
Publikováno v:
Veterinary and Comparative Orthopaedics and Traumatology. 12:151-155
The purpose of the study is to document the prevalence of articular surface osteochondrosis lesions in feral horses. Eighty yearling feral horses were used. Radiographic images of the left stifle, both tarsocrural, metatarsophalangeal, metacarpophala